Holen Sie sich die Stockscreener-App
9.01
3.68%
0.32
Schlusskurs vom Vortag:
$8.69
Offen:
$8.7
24-Stunden-Volumen:
261.45K
Relative Volume:
1.82
Marktkapitalisierung:
$251.56M
Einnahmen:
$242.12M
Nettoeinkommen (Verlust:
$-351.72M
KGV:
-0.678
EPS:
-13.29
Netto-Cashflow:
$24.82M
1W Leistung:
+2.85%
1M Leistung:
-2.59%
6M Leistung:
-32.71%
1J Leistung:
-46.94%
1-Tages-Spanne:
$8.545
$9.02
1-Wochen-Bereich:
$8.545
$9.345
52-Wochen-Spanne:
$8.545
$22.40
Zimvie Inc Stock (ZIMV) Company Profile
Firmenname
Zimvie Inc
Sektor
Branche
Telefon
800-342-5454
Adresse
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Vergleichen Sie ZIMV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZIMV
Zimvie Inc
|
9.01 | 244.59M | 242.12M | -351.72M | 24.82M | -13.29 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2024-05-16 | Hochstufung | Needham | Hold → Buy |
| 2023-11-16 | Eingeleitet | Needham | Hold |
| 2022-12-21 | Eingeleitet | Barclays | Underweight |
| 2022-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-03-18 | Eingeleitet | Guggenheim | Neutral |
Alle ansehen
Zimvie Inc Aktie (ZIMV) Neueste Nachrichten
When the Price of (ZIMV) Talks, People Listen - news.stocktradersdaily.com
UBS cuts ZimVie stock price target to $10 from $16, stays neutral - Investing.com Nigeria
ZimVie (ZIMV) Price Target Lowered by UBS Analyst | ZIMV Stock N - GuruFocus
UBS Adjusts Price Target on ZimVie to $10 From $16, Maintains Neutral Rating - marketscreener.com
ZimVie (ZIMV) Price Target Lowered by UBS Analyst | ZIMV Stock News - GuruFocus
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference - The Manila Times
ZimVie Inc. (NASDAQ:ZIMV) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ZimVie Q1 2025 earnings beat expectations By Investing.com - Investing.com Nigeria
Needham maintains Hold on ZimVie stock after Q1 results By Investing.com - Investing.com South Africa
ZimVie Reports First Quarter 2025 Financial Results - Dentistry Today
Needham maintains Hold on ZimVie stock after Q1 results - Investing.com
ZimVie Q1 2025 slides: Profitability surges despite revenue headwinds - Investing.com
ZimVie Q1 2025 slides: Profitability surges despite revenue headwinds By Investing.com - Investing.com Nigeria
ZimVie Inc (ZIMV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... By GuruFocus - Investing.com Canada
ZimVie Inc. Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: ZimVie Q1 2025 earnings beat expectations - Investing.com
ZimVie Inc Reports Q1 2025 Financial Results - TipRanks
Dimensional Fund Advisors LP Increases Stake in ZimVie Inc. (NASDAQ:ZIMV) - Defense World
Wells Fargo & Company MN Raises Holdings in ZimVie Inc. (NASDAQ:ZIMV) - Defense World
ZimVie Inc expected to post earnings of 21 cents a shareEarnings Preview - TradingView
How to Take Advantage of moves in (ZIMV) - news.stocktradersdaily.com
ZimVie Schedules Q1 Earnings Call - Dentistry Today
ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Dental Market Leader ZimVie Sets Q1 2025 Earnings Release DateKey Financial Updates Coming May 8 - Stock Titan
Geode Capital Management LLC Sells 3,771 Shares of ZimVie Inc. (NASDAQ:ZIMV) - Defense World
Spine Equipment Market Future Prospects 2031 | Medtronic, Alphatec Spine, ZimVie - newstrail.com
ZimVie Inc. (NASDAQ:ZIMV) Shares Acquired by JPMorgan Chase & Co. - Defense World
71,216 Shares in ZimVie Inc. (NASDAQ:ZIMV) Acquired by LPL Financial LLC - Defense World
Zimvie Inc. Announces the Launch of Its Immediate Molar Implant System in the United States - marketscreener.com
ZimVie announces launch of its Immediate Molar Implant system in US - TipRanks
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System - The Manila Times
Renaissance Technologies LLC Sells 32,900 Shares of ZimVie Inc. (NASDAQ:ZIMV) - Defense World
Learn to Evaluate (ZIMV) using the Charts - news.stocktradersdaily.com
Vanguard Group Inc. Boosts Position in ZimVie Inc. (NASDAQ:ZIMV) - Defense World
B. Riley Weighs in on ZimVie’s Q1 Earnings (NASDAQ:ZIMV) - Defense World
B. Riley Initiates Coverage on ZimVie (NASDAQ:ZIMV) - Defense World
ZimVie (NASDAQ:ZIMV) Upgraded at B. Riley - Defense World
Needham & Company LLC Reaffirms “Hold” Rating for ZimVie (NASDAQ:ZIMV) - Defense World
B.Riley sets ZimVie stock Buy rating, $16 price target - Investing.com Australia
B. Riley Initiates ZimVie at Buy With $16 Price Target - marketscreener.com
ZimVie initiated with a Buy at B. Riley - TipRanks
B.Riley sets ZimVie stock Buy rating, $16 price target By Investing.com - Investing.com India
Prudential Financial Inc. Invests $681,000 in ZimVie Inc. (NASDAQ:ZIMV) - Defense World
ZimVie at Needham Conference: Navigating Market Challenges By Investing.com - Investing.com India
ZimVie at Needham Conference: Navigating Market Challenges - Investing.com
ZimVie stock touches 52-week low at $9.05 amid market challenges - Investing.com Australia
ZimVie stock touches 52-week low at $9.05 amid market challenges By Investing.com - Investing.com South Africa
(ZIMV) Trading Report - news.stocktradersdaily.com
ZimVie Inc. (NASDAQ:ZIMV) Shares Purchased by American Century Companies Inc. - The AM Reporter
ZimVie stock touches 52-week low at $11 amid market challenges By Investing.com - Investing.com South Africa
ZimVie stock touches 52-week low at $11 amid market challenges - Investing.com India
Finanzdaten der Zimvie Inc-Aktie (ZIMV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):